# Phase 300 — Numerical admission integration (2026-11-10)

## Scope and verified result
Integrated the existing Phase 299 `finite_float` input gate into the Phase 296 `safe_weighted_mean` helper, after reading both original files and the Phase 298 expected-failure test. The change converts unrepresentably large integer inputs into a consistent `ValueError` rather than an uncaught `OverflowError`. It preserves strict positive-weight checks and rejects Boolean and nonfinite inputs.

Eight deterministic integration tests passed in a local Python unittest run (8 run, 0 failures, 0 errors). The tests use synthetic arithmetic only. The Phase 298 expected-failure decorator was subsequently removed and the regression promoted to an ordinary passing-condition test; this updated test was committed but not executed in the published checkout. The published checkout was not separately executed.

## Limitations
This helper is not yet integrated into the Phase 289 common-date bootstrap. No SEC source files, exchange calendar, historical treatment assignment, matched roster, or previously recovered ZIP were authenticated in this session. No September pretrend, October placebo, November treatment estimate, or historical inference was computed. In particular, the substantial October 2025 placebo warning and September pretrends prohibit causal claims.

## Next
Reconcile the Phase 298 expected-failure decorator, execute the full published suite, and prioritize authenticated SEC input and roster provenance before empirical inference. Keep the November 14 target conditional on validation. No redistributable third-party data or synthetic market figures were added.
